However, another recent study on 163 patients with different types of cancers, including 34 lung cancer patients, and 13 healthy controls in Germany showed that serum IGFBP2 levels were only significantly elevated in head and neck tumors but not in other types of cancer, including lung cancer [34]. The gene discussed is IGFBP2; the disease is lung carcinoma.